#aaeth ,,congress #b;d ,session ,h4 ,r4 #bhea ,,an ,,act ,to amend the ,controlled ,substances ,act to clarify how controlled substance analogues are to be regulated1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,stop the ,importation and ,trafficking of ,synthetic ,analogues ,act of #bjag or the ,,sitsa ,act4 #b4 ,establishment of ,schedule ,a ,section #bjb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7 is amended-- 7#a7 in subsection 7a71 by striking five schedules of controlled substances1 to be known as schedules ,i1 ,,ii1 ,,iii1 ,,iv1 and ,v and inserting six schedules of controlled substances1 to be known as schedules ,i1 ,,ii1 ,,iii1 ,,iv1 ,v1 and ,a2 7#b7 in subsection 7b71 by adding at the end the following3 7#f7 ,schedule ,a 7,a7 ,in general ,the drug or substance-- 7i7 has-- 7,i7 a chemical structure that is substantially similar to the chemical structure of a controlled substance in schedule ,i1 ,,ii1 ,,iii1 ,,iv1 or ,v2 and 7,,ii7 an actual or predicted stimulant1 depressant1 or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant1 depressant1 or hallucinogenic effect on the central nervous system of a controlled substance in schedule ,i1 ,,ii1 ,,iii1 ,,iv1 or ,v2 and 7ii7 is not-- 7,i7 listed or otherwise included in any other schedule in this section or by regulation of the ,attorney ,general2 and 7,,ii7 with respect to a particular person1 subject to an exemption that is in effect for investigational use1 for that person1 under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 to the extent conduct with respect to such substance is pursuant to such exemption4 7,b7 ,predicted stimulant1 depressant1 or hallucinogenic effect ,for purpose of this paragraph1 a predicted stimulant1 depressant1 or hallucinogenic effect on the central nervous system may be based on-- 7i7 the chemical structure and-- 7,i7 the structure activity relationships2 or 7,,ii7 binding receptor assays and other relevant scientific information about the substance2 7ii7 7,i7 the current or relative potential for abuse of the substance2 and 7,,ii7 the clandestine importation1 manufacture1 or distribution1 or diversion from legitimate channels1 of the substance2 or 7iii7 the capacity of the substance to cause a state of dependence1 including physical or psychological dependence that is similar to or greater than that of a controlled substance in schedule ,i1 ,,ii1 ,,iii1 ,,iv1 or ,v4 2 and 7#c7 in subsection 7c71 in the matter preceding schedule ,i1 by striking ,,iv1 and ,v and inserting ,,iv1 ,v1 and ,a4 #c4 ,temporary and permanent scheduling of schedule ,a substances ,section #bja of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #haa7 is amended by adding at the end the following3 7k7 ,temporary and permanent scheduling of schedule ,a substances 7#a7 ,the ,attorney ,general may issue a temporary order adding a drug or substance to schedule ,a if the ,attorney ,general finds that-- 7,a7 the drug or other substance satisfies the criteria for being considered a schedule ,a substance2 and 7,b7 adding such drug or substance to schedule ,a will assist in preventing abuse of the drug or other substance4 7#b7 ,a temporary scheduling order issued under paragraph 7#a7 shall not take effect until #cj days after the date of the publication by the ,attorney ,general of a notice in the ,federal ,register of the intention to issue such order and the grounds upon which such order is to be issued4 ,the temporary scheduling order shall expire not later than #e years after the date it becomes effective1 except that the ,attorney ,general may1 during the pendency of proceedings under paragraph 7#e71 extend the temporary scheduling order for up to #ahj days4 7#c7 ,a temporary scheduling order issued under paragraph 7#a7 shall be vacated upon the issuance of a permanent order issued under paragraph 7#e7 with regard to the same substance1 or upon the subsequent issuance of any scheduling order under this section4 7#d7 ,a temporary scheduling order issued under paragraph 7#a7 shall not be subject to judicial review4 7#e7 7,a7 ,beginning no earlier than #c years after issuing an order temporarily scheduling a drug or other substance under this subsection1 the ,attorney ,general may1 by rule1 issue a permanent order adding a drug or other substance to schedule ,a if such drug or substance satisfies the criteria for being considered a controlled substance in schedule ,a under this subsection1 except as provided in subparagraph 7,b74 7,b7 ,if the ,secretary has determined1 based on relevant scientific studies and necessary data requested by the ,secretary and gathered by the ,attorney ,general1 that a drug or other substance that has been temporarily placed in schedule ,a does not have sufficient potential for abuse to warrant control in any schedule1 and so advises the ,attorney ,general in writing1 the ,attorney ,general may not issue a permanent scheduling order under subparagraph 7,a7 and shall1 within #cj days of receiving the ,secretary's advice issue an order immediately terminating the temporary scheduling order4 7#f7 ,before initiating proceedings under paragraph 7#a71 the ,attorney ,general shall transmit notice of a temporary order proposed to be issued to the ,secretary of ,health and ,human ,services4 ,in issuing an order under paragraph 7#a71 the ,attorney ,general shall take into consideration any comments submitted by the ,secretary of ,health and ,human ,services in response to a notice transmitted pursuant to this paragraph4 7#g7 ,on the date of the publication of a notice in the ,federal ,register pursuant to paragraph 7#b71 the ,attorney ,general shall transmit the same notice to ,congress4 ,the temporary scheduling order shall take effect according to paragraph 7#b71 except that the temporary scheduling order may be disapproved by an ,act of ,congress within #ahj days from the date of publication of the notice in the ,federal ,register4 4 #d4 ,penalties 7a7 ,controlled ,substances ,act ,the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 is amended-- 7#a7 in section #dja7;b77#a7 7#ba ,u4,s4,c4 #hda7;b77#a771 by adding at the end the following3 7,f7 7i7 ,in the case of any controlled substance in schedule ,a1 such person shall be sentenced to a term of imprisonment of not more than #aj years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not more than #ae years1 a fine not to exceed the greater of that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #ejj1jjj if the defendant is an individual or #b4e million if the defendant is other than an individual1 or both4 7ii7 ,if any person commits such a violation after a prior conviction for a felony drug offense has become final1 such person shall be sentenced to a term of imprisonment of not more than #bj years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not more than #cj years1 a fine not to exceed the greater of twice that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #a million if the defendant is an individual or #e million if the defendant is other than an individual1 or both4 7iii7 ,any sentence imposing a term of imprisonment under this subparagraph shall1 in the absence of such a prior conviction1 impose a term of supervised release of not less than #b years in addition to such term of imprisonment and shall1 if there was such a prior conviction1 impose a term of supervised release of not less than #d years in addition to such term of imprisonment4 2 7#b7 in section #djc7;a7 7#ba ,u4,s4,c4 #hdc7;a77-- 7,a7 in paragraph 7#h71 by striking or at the end2 7,b7 in paragraph 7#i71 by striking the period at the end and inserting 2 or2 and 7,c7 by inserting after paragraph 7#i7 the following3 7#aj7 to export a substance in violation of the controlled substance laws of the country to which the substance is exported4 2 and 7#c7 in section #djd 7#ba ,u4,s4,c4 #hdd71 by inserting after subsection 7a7 the following3 7b7 ,a person shall not be subject to a criminal or civil penalty under this title or under any other ,federal law solely for possession of a schedule ,a controlled substance4 4 7b7 ,controlled ,substances ,import and ,export ,act ,section #ajaj7;b7 of the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #ifj7;b77 is amended by adding at the end the following3 7#h7 ,in the case of a violation under subsection 7a7 involving a controlled substance in schedule ,a1 the person committing such violation shall be sentenced to a term of imprisonment of not more than #bj years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not more than life1 a fine not to exceed the greater of that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #a million if the defendant is an individual or #e million if the defendant is other than an individual1 or both4 ,if any person commits such a violation after a prior conviction for a felony drug offense has become final1 such person shall be sentenced to a term of imprisonment of not more than #cj years and if death or serious bodily injury results from the use of such substance shall be sentenced to not more than life imprisonment1 a fine not to exceed the greater of twice that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #b million if the defendant is an individual or #aj million if the defendant is other than an individual1 or both4 ,notwithstanding section #cehc of title #ah1 ,united ,states ,code1 any sentence imposing a term of imprisonment under this paragraph shall1 in the absence of such a prior conviction1 impose a term of supervised release of not less than #c years in addition to such term of imprisonment and shall1 if there was such a prior conviction1 impose a term of supervised release of not less than #f years in addition to such term of imprisonment4 ,notwithstanding the prior sentence1 and notwithstanding any other provision of law1 the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this paragraph which provide for a mandatory term of imprisonment if death or serious bodily injury results4 4 #e4 ,false labeling of schedule ,a controlled substances 7a7 ,in general ,section #cje of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbe7 is amended by adding at the end the following3 7f7 ,false labeling of schedule ,a controlled substances 7#a7 ,it shall be unlawful to import1 export1 manufacture1 distribute1 dispense1 or possess with intent to manufacture1 distribute1 or dispense1 a schedule ,a substance or product containing a schedule ,a substance1 unless the substance or product bears a label clearly identifying a schedule ,a substance or product containing a schedule ,a substance by the nomenclature used by the ,international ,union of ,pure and ,applied ,chemistry 7,,iupac74 7#b7 7,a7 ,a product described in subparagraph 7,b7 is exempt from the ,international ,union of ,pure and ,applied ,chemistry nomenclature requirement of this subsection if such product is labeled in the manner required under the ,federal ,food1 ,drug1 and ,cosmetic ,act4 7,b7 ,a product is described in this subparagraph if the product-- 7i7 is the subject of an approved application as described in section #eje7;b7 or 7j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act2 or 7ii7 is exempt from the provisions of section #eje of such ,act relating to new drugs because-- 7,i7 it is intended solely for investigational use as described in section #eje7;i7 of such ,act2 and 7,,ii7 such product is being used exclusively for purposes of a clinical trial that is the subject of an effective investigational new drug application4 4 7b7 ,penalties ,section #djb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hdb7 is amended-- 7#a7 in subsection 7a77#af71 by inserting or subsection 7f7 after subsection 7e72 and 7#b7 in subsection 7c77#a77;,d71 by inserting or a schedule ,a substance after anabolic steroid4 #f4 ,registration requirements for handlers of schedule ,a substances 7a7 ,controlled ,substances ,act ,section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7 is amended by adding at the end the following3 7k7 7#a7 ,the ,attorney ,general shall register an applicant to manufacture schedule ,a substances if-- 7,a7 the applicant demonstrates that the schedule ,a substances will be used for research1 analytical1 or industrial purposes approved by the ,attorney ,general2 and 7,b7 the ,attorney ,general determines that such registration is consistent with the public interest and with the ,united ,states obligations under international treaties1 conventions1 or protocols in effect on the date of enactment of this subsection4 7#b7 ,in determining the public interest under paragraph 7#a77;,b71 the ,attorney ,general shall consider-- 7,a7 maintenance of effective controls against diversion of particular controlled substances and any controlled substance in schedule ,a compounded therefrom into other than legitimate medical1 scientific1 research1 or industrial channels1 by limiting the importation and bulk manufacture of such controlled substances to a number of establishments which can produce an adequate and uninterrupted supply of these substances under adequately competitive conditions for legitimate medical1 scientific1 research1 and industrial purposes2 7,b7 compliance with applicable ,state and local law2 7,c7 promotion of technical advances in the art of manufacturing substances described in subparagraph 7,a7 and the development of new substances2 7,d7 prior conviction record of applicant under ,federal and ,state laws relating to the manufacture1 distribution1 or dispensing of substances described in paragraph 7,a72 7,e7 past experience in the manufacture of controlled substances1 and the existence in the establishment of effective control against diversion2 and 7,f7 such other factors as may be relevant to and consistent with the public health and safety4 7#c7 ,if an applicant is registered to manufacture controlled substances in schedule ,i or ,,ii under subsection 7a71 the applicant shall not be required to apply for a separate registration under this subsection4 7l7 7#a7 ,the ,attorney ,general shall register an applicant to distribute schedule ,a substances-- 7,a7 if the applicant demonstrates that the schedule ,a substances will be used for research1 analytical1 or industrial purposes approved by the ,attorney ,general2 and 7,b7 unless the ,attorney ,general determines that the issuance of such registration is inconsistent with the public interest4 7#b7 ,in determining the public interest under paragraph 7#a77;,b71 the ,attorney ,general shall consider-- 7,a7 maintenance of effective control against diversion of particular controlled substances into other than legitimate medical1 scientific1 and industrial channels2 7,b7 compliance with applicable ,state and local law2 7,c7 prior conviction record of applicant under ,federal or ,state laws relating to the manufacture1 distribution1 or dispensing of substances described in subparagraph 7,a72 7,d7 past experience in the distribution of controlled substances2 and 7,e7 such other factors as may be relevant to and consistent with the public health and safety4 7#c7 ,if an applicant is registered to distribute a controlled substance in schedule ,i or ,,ii under subsection 7b71 the applicant shall not be required to apply for a separate registration under this subsection4 7m7 7#a7 7,a7 ,not later than #ij days after the date on which a substance is placed in schedule ,a1 any practitioner who was engaged in research on the substance before the placement of the substance in schedule ,a and any manufacturer or distributor who was handling the substance before the placement of the substance in schedule ,a shall register with the ,attorney ,general4 7,b7 7i7 ,if an applicant described in subparagraph 7,a7 is registered pursuant to subsection 7f7 to conduct research with a controlled substance in schedule ,i or ,,ii on the date on which another substance is placed in schedule ,a1 the applicant may1 subject to clause 7iii71 conduct research with that other controlled substance in schedule ,a while the application for registration pursuant to subparagraph 7,a7 is pending4 7ii7 ,if an applicant described in subparagraph 7,a7 is registered pursuant to subsection 7f7 as described in clause 7i7 to conduct research with a controlled substance in schedule ,,iii1 ,,iv1 or ,v on the date on which another substance is placed in schedule ,a1 the applicant may1 subject to clause 7iii71 conduct research with that other controlled substance in schedule ,a while the application for registration pursuant to subparagraph 7,a7 is pending1 provided the substance for which the applicant is registered to conduct research is in the same schedule as1 or a less-restricted schedule than1 the controlled substance whose similarity in chemical structure and actual or predicted effect to the controlled substance in schedule ,a formed the basis for placement of the substance in schedule ,a1 as set forth in the order published in the ,federal ,register placing the substance in schedule ,a4 7iii7 ,the permission to conduct research pursuant to clause 7i7 or clause 7ii7 is conditional on the applicant's complying with the registration and other requirements for controlled substances in schedule ,a4 7iv7 ,this subparagraph does not apply to applicants registered pursuant to subsection 7f7 whose authorization to conduct research with any controlled substances is limited to doing so as a coincident activity pursuant to applicable regulations of the ,attorney ,general4 7#b7 7,a7 ,not later than #fj days after the date on which the ,attorney ,general receives an application for registration to conduct research on a schedule ,a substance1 the ,attorney ,general shall-- 7i7 grant1 or initiate proceedings under section #cjd7;c7 to deny1 the application2 or 7ii7 request supplemental information from the applicant4 7,b7 ,not later than #cj days after the date on which the ,attorney ,general receives supplemental information requested under subparagraph 7,a77ii7 in connection with an application described in subparagraph 7,a71 the ,attorney ,general shall grant or deny the application4 7n7 7#a7 ,the ,attorney ,general shall register a scientific investigator or a qualified research institution to conduct research with controlled substances in schedule ,a in accordance with this subsection4 ,in evaluating applications for such registration1 the ,attorney ,general shall apply the criteria set forth in subsection 7f7 of this section that apply to practitioners seeking a registration to conduct research with a schedule ,i controlled substance1 except that the applicant shall not be required to submit a research protocol4 7#b7 ,if the applicant is not currently registered under subsection 7f7 to conduct research with a schedule ,i controlled substance1 the ,attorney ,general shall refer the application to the ,secretary1 who shall determine whether the applicant will be engaged in bona fide research and is qualified to conduct such research4 ,the #fj-;day period under subsection 7m77#b77;,a7 shall be tolled during the period beginning on the date on which the ,attorney ,general refers an application to the ,secretary under this paragraph1 and ending on the date on which the ,secretary submits a determination related to such referral to the ,attorney ,general4 7#c7 ,an applicant who meets the criteria under subsection 7m77#a77;,b7 with respect to a particular schedule ,a controlled substance shall be considered qualified to conduct research with that substance4 ,the ,attorney ,general shall modify such applicant's registration to include such schedule ,a controlled substance in accordance with this paragraph4 ,the applicant shall notify the ,attorney ,general of his intent to conduct research with a controlled substance in schedule ,a4 ,upon receiving such notification1 the ,attorney ,general shall modify the practitioner's existing registration to authorize research with schedule ,a controlled substances1 unless the ,attorney ,general determines that the registration modification would be inconsistent with the public interest based on the criteria of subsection 7f74 7#d7 ,registrations issued under this subsection to a qualified research institution will apply to all agents and employees of that institution acting within the scope of their professional practice4 7#e7 ,at least #cj days prior to conducting any research with a controlled substance in schedule ,a1 the registrant shall provide the ,attorney ,general with written notification of the following3 7,a7 ,the name of and drug code for each substance4 7,b7 ,the name of each individual with access to each substance4 7,c7 ,the amount of each substance4 7,d7 ,other similar information the ,attorney ,general may require4 7#f7 ,the quantity of a schedule ,a controlled substance possessed by a person registered under this subsection shall be appropriate for the research being conducted1 subject to the additional limitations set forth in this paragraph4 ,to reduce the risk of diversion1 the ,attorney ,general may establish limitations on the quantity of schedule ,a controlled substances that may be manufactured or possessed for purposes of research under this subsection and shall publish such limitations on the website of the ,drug ,enforcement ,administration4 ,a person registered under this subsection may1 based on legitimate research needs1 apply to the ,attorney ,general to manufacture or possess an amount greater than that so specified by the ,attorney ,general4 ,the ,attorney ,general shall specify the manner in which such applications shall be submitted4 ,the ,attorney ,general shall act on an application filed under this subparagraph within #cj days of receipt of such application4 ,if the ,attorney ,general fails to act within #cj days1 the registrant shall be allowed to manufacture and possess up to the amount requested4 ,the ,attorney ,general shall have the authority to reverse the increase for cause4 7#g7 ,the ,attorney ,general shall by regulation specify the manner in which applications for registration under this subsection shall be submitted4 7#h7 ,registrants authorized under this subsection may manufacture and possess schedule ,a controlled substances up to the approved amounts only for use in their own research setting or institution4 ,manufacturing for use in any other setting or institution shall require a manufacturer's registration under section #cjc7;a74 4 7b7 ,controlled ,substances ,import and ,export ,act ,section #ajjh of the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #ieh7 is amended by adding at the end the following3 7j7 7#a7 ,the ,attorney ,general shall register an applicant to import or export a schedule ,a substance if-- 7,a7 the applicant demonstrates that the schedule ,a substances will be used for research1 analytical1 or industrial purposes approved by the ,attorney ,general2 and 7,b7 the ,attorney ,general determines that such registration is consistent with the public interest and with the ,united ,states obligations under international treaties1 conventions1 or protocols in effect on the date of enactment of this subsection4 7#b7 ,in determining the public interest under paragraph 7#a77;,b71 the ,attorney ,general shall consider the factors described in subparagraphs 7,a7 through 7,f7 of section #cjc7k77#b74 7#c7 ,if an applicant is registered to import or export a controlled substance in schedule ,i or ,,ii under subsection 7a71 the applicant shall not be required to apply for a separate registration under this subsection4 4 #g4 ,additional conforming amendments 7a7 ,controlled ,substances ,act ,the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 is amended-- 7#a7 in section #cjc7;c7 7#ba ,u4,s4,c4 #hbc7;c77-- 7,a7 by striking subsections 7a7 and 7b7 and inserting subsection 7a71 7b71 7k71 or 7l72 and 7,b7 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7#b7 in section #cjf 7#ba ,u4,s4,c4 #hbf7-- 7,a7 in subsection 7a71 in the first sentence1 by striking schedules ,i and ,,ii and inserting schedules ,i1 ,,ii1 and ,a2 7,b7 in subsection 7b71 in the second sentence1 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7,c7 in subsection 7c71 in the first sentence1 by striking schedules ,i and ,,ii and inserting schedules ,i1 ,,ii1 and ,a2 7,d7 in subsection 7d71 in the first sentence1 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7,e7 in subsection 7e71 in the first sentence1 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7,f7 in subsection 7f71 in the first sentence1 by striking schedules ,i and ,,ii and inserting schedules ,i1 ,,ii1 and ,a2 7#c7 in section #cjh7;a7 7#ba ,u4,s4,c4 #hbh7;a771 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7#d7 in section #djb7;b7 7#ba ,u4,s4,c4 #hdb7;b771 in the matter preceding paragraph 7#a71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7#e7 in section #djc7;a77#a7 7#ba ,u4,s4,c4 #hdc7;a77#a771 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7#f7 in section #eaa7;f7 7#ba ,u4,s4,c4 #hha7;f771 by striking schedule ,i or ,,ii each place it appears and inserting schedule ,i1 ,,ii1 or ,a4 7b7 ,controlled ,substances ,import ,export ,act ,the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #iea et seq47 is amended-- 7#a7 in section #ajjb7;a7 7#ba ,u4,s4,c4 #ieb7;a77-- 7,a7 in the matter preceding paragraph 7#a71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7,b7 in paragraph 7#b71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7#b7 in section #ajjc 7#ba ,u4,s4,c4 #iec7-- 7,a7 in subsection 7c71 in the matter preceding paragraph 7#a71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7,b7 in subsection 7d71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7#c7 in section #ajjd7a7 7#ba ,u4,s4,c4 #ied7a771 by striking schedule ,i and inserting schedule ,i or ,a2 7#d7 in section #ajje 7#ba ,u4,s4,c4 #iee71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7#e7 in section #ajji7;a7 7#ba ,u4,s4,c4 #iei7;a771 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a4 #h4 ,controlled substance analogues ,section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb7 is amended-- 7#a7 in paragraph 7#f71 by striking or ,v and inserting ,v1 or ,a2 7#b7 in paragraph 7#ad7-- 7,a7 by striking schedule ,i7c7 and and inserting schedule ,i7c71 schedule ,a1 and2 and 7,b7 by striking schedule ,i7c71 and inserting schedule ,i7c7 and schedule ,a12 and 7#c7 in paragraph 7#cb77;,a71 by striking 7#cb77;,a7 and all that follows through clause 7iii7 and inserting the following3 7#cb7 7,a7 ,except as provided in subparagraph 7,c71 the term controlled substance analogue means a substance whose chemical structure is substantially similar to the chemical structure of a controlled substance in schedule ,i or ,,ii-- 7i7 which has a stimulant1 depressant1 or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant1 depressant1 or hallucinogenic effect on the central nervous system of a controlled substance in schedule ,i or ,,ii2 or 7ii7 with respect to a particular person1 which such person represents or intends to have a stimulant1 depressant1 or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant1 depressant1 or hallucinogenic effect on the central nervous system of a controlled substance in schedule ,i or ,,ii4 4 #i4 ,rules of construction ,nothing in this ,act1 or the amendments made by this ,act1 may be construed to limit-- 7#a7 the prosecution of offenses involving controlled substance analogues under the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq472 or 7#b7 the authority of the ,attorney ,general to temporarily or permanently schedule1 reschedule1 or decontrol controlled substances under provisions of section #bja of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #haa7 that are in effect on the day before the date of enactment of this ,act4 #aj4 ,study by ,comptroller ,general ,not later than #b years after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall complete a study and submit a report to the ,committees on the ,judiciary of the ,house of ,representatives and of the ,senate regarding the costs associated with the amendments made by section #d1 including-- 7#a7 the annual amounts expended by ,federal agencies in carrying out the amendments2 7#b7 the costs associated with arrests1 trials1 convictions1 imprisonment1 or imposition of other sanctions in accordance with the amendments2 and 7#c7 the impact 7including the fiscal impact7 of the amendments on existing correctional facilities and the likelihood that those amendments will create a need for additional capacity for housing prisoners4 #aa4 ,report on controlled substance analogues sold by means of the ,internet ,not later than #a year after the date of the enactment of this ,act1 and annually thereafter1 the ,administrator of the ,drug ,enforcement ,administration shall make publicly available on the website of the ,drug ,enforcement ,administration a report on1 for the previous year1 the lawful and unlawful sale of controlled substance analogues 7as defined in section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb77 by means of the ,internet1 including the following information3 7#a7 ,the types of controlled substance analogues that were sold1 and the number of sales for each such substance4 7#b7 ,the name of each person1 entity1 or ,internet site1 whether in the ,united ,states or abroad1 that knowingly or intentionally delivers1 distributes1 or dispenses1 or offers or attempts to deliver1 distribute1 or dispense1 a controlled substance analogue by means of the ,internet1 whether lawfully or unlawfully4 7#c7 ,an estimate of the total revenue for all of the vendors described in paragraph 7#b7 for all of the sales described in paragraph 7#a74 #ab4 ,controlled substance analogues ,section #bjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hac7 is amended-- 7#a7 by striking ,a controlled and inserting 7a7 ,in general4--,a controlled2 and 7#b7 by adding at the end the following3 7b7 ,determination ,in determining whether a controlled substance analogue was intended for human consumption under subsection 7a71 the following factors may be considered1 along with any other relevant factors3 7#a7 ,the marketing1 advertising1 and labeling of the substance4 7#b7 ,the known efficacy or usefulness of the substance for the marketed1 advertised or labeled purpose4 7#c7 ,the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold4 7#d7 ,the diversion of the substance from legitimate channels and the clandestine importation1 manufacture1 or distribution of the substance4 7#e7 ,whether the defendant knew or should have known the substance was intended to be consumed by injection1 inhalation1 ingestion1 or any other immediate means4 7#f7 ,any controlled substance analogue that is manufactured1 formulated1 sold1 distributed1 or marketed with the intent to avoid the provisions of existing drug laws4 7c7 ,limitation ,for purposes of this section1 evidence that a substance was not marketed1 advertised1 or labeled for human consumption1 by itself1 shall not be sufficient to establish that the substance was not intended for human consumption4 4 ,passed the ,house of ,representatives ,june #ae1 #bjah4;,clerk4